Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00145275
Status:
COMPLETED
Last Update Posted:
2012-04-27
First Post:
2005-09-01
Brief Title:
To Assess the Efficacy of Over-the-counter Analgesics in the PreventionTreatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal Women
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
To Assess the Efficacy of Over-the-counter Analgesics in the PreventionTreatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal Women
Status:
COMPLETED
Status Verified Date:
2012-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Zoledronic acid is a medicine being studied in people with low bone mass Side effects such as headache fever muscle aches and pains may occur following the infusion This study will investigate the use of over-the-counter medicines to improve these symptoms
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None